Literature DB >> 18443959

FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma.

Hiromi Mukaide1, Yasushi Adachi, Shigeru Taketani, Masayoshi Iwasaki, Naoko Koike-Kiriyama, Akio Shigematsu, Ming Shi, Seiji Yanai, Kazuhiko Yoshioka, Yasuo Kamiyama, Susumu Ikehara.   

Abstract

It has been reported, as a result of Western blot analyses, that FKBP51 is expressed in various tissues, but that it is not expressed in the pancreas, lung, colon, stomach, or spleen. In this paper, we show, using Western blot analyses, reverse transcriptase polymerase chain reaction, and immunohistochemical analyses of samples from colon cancer patients, that both normal epithelial cells and adenocarcinoma in the human colon express FKBP51, and that there are no significant differences in the expressions of FKBP51 between them. We also show that FKBP51 suppresses the proliferation of colorectal adenocarcinoma, possibly due to the suppression of functions of the glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443959     DOI: 10.1080/07357900701799228

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

Review 1.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

2.  Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.

Authors:  Mariana Lagadari; Nadia R Zgajnar; Luciana I Gallo; Mario D Galigniana
Journal:  Mol Oncol       Date:  2016-05-17       Impact factor: 6.603

3.  IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment.

Authors:  Deborah Rotoli; Manuel Morales; María-Del-C Maeso; Julio Ávila; Natalia D Pérez-Rodríguez; Ali Mobasheri; Cornelis J F van Noorden; Pablo Martín-Vasallo
Journal:  J Histochem Cytochem       Date:  2019-02-22       Impact factor: 2.479

4.  Androgen Receptor and Androgen-Responsive Gene FKBP5 Are Independent Prognostic Indicators for Esophageal Adenocarcinoma.

Authors:  Eric Smith; Helen M Palethorpe; Andrew R Ruszkiewicz; Suzanne Edwards; Damien A Leach; Tim J Underwood; Eleanor F Need; Paul A Drew
Journal:  Dig Dis Sci       Date:  2016-02       Impact factor: 3.199

5.  FK506-binding protein 5 promotes the progression of papillary thyroid carcinoma.

Authors:  Zhenya Gao; Fang Yu; Huanxia Jia; Zhuo Ye; Shijie Yao
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

Review 6.  The role of FKBP5 in cancer aetiology and chemoresistance.

Authors:  L Li; Z Lou; L Wang
Journal:  Br J Cancer       Date:  2010-11-30       Impact factor: 7.640

7.  Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy.

Authors:  Deborah Rotoli; Manuel Morales; Julio Ávila; María Del Carmen Maeso; María Del Pino García; Ali Mobasheri; Pablo Martín-Vasallo
Journal:  Int J Mol Sci       Date:  2017-04-22       Impact factor: 5.923

Review 8.  Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52

Authors:  Nadia R Zgajnar; Sonia A De Leo; Cecilia M Lotufo; Alejandra G Erlejman; Graciela Piwien-Pilipuk; Mario D Galigniana
Journal:  Biomolecules       Date:  2019-02-01

9.  Expression and localization of the immunophilin FKBP51 in colorectal carcinomas and primary metastases, and alterations following oxaliplatin-based chemotherapy.

Authors:  Deborah Rotoli; Manuel Morales; María Del Carmen Maeso; María Del Pino García; Araceli Morales; Julio Ávila; Pablo Martín-Vasallo
Journal:  Oncol Lett       Date:  2016-06-23       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.